Dr. Odeniyideis an Instructor in the Division of Pediatric Oncology. Her research focuses on RAS-directed therapies for pediatric rhabdomyosarcoma and her clinical expertise is in the treatment of pediatric solid tumors. Dr. Odeniyide received her undergraduate degree from the University of North Carolina at Chapel Hill and earned her MD from Indiana University School of Medicine. She did her general pediatric residency at the University of North Carolina at Chapel Hill and completed her pediatric hematology/oncology fellowship at Johns Hopkins/ NIH Pediatric Oncology Branch Pediatric Hematology/Oncology joint fellowship training program in 2017. She completed her Ph.D. in cellular and molecular medicine at Johns Hopkins School of Medicine in 2022. 

Dr. Odeniyide aims to develop and implement novel molecularly targeted therapeutics to treat pediatric cancers with genetic alterations. Her research is focused on the application of small molecule therapeutics for tumors with RAS mutations, a common mutation in cancer for which few effective targeted therapies exist. Her goal is that her research will bring more effective therapeutic options for pediatric sarcoma patients. more


  • Instructor of Oncology

Departments / Divisions



  • MD; Medicine; Indiana University School of Medicine (2014)


  • Pediatrics; University of North Carolina at Chapel Hill (2017)


  • Pediatric Oncology; Johns Hopkins University School of Medicine (2022)

Board Certifications

  • American Board of Pediatrics (Pediatric Hematology-Oncology) (2021)
  • American Board of Pediatrics (Pediatrics) (2018)

Research & Publications

Selected Publications

Odeniyide P, Yohe ME, Pollard K, Vaseva AV, Calizo A, Zhang L, Rodriguez FJ, Gross JM, Allen AN, Wan X, Somwar R, Schreck KC, Kessler L, Wang J, Pratilas CA. Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma. Oncogene. 2022 Apr 22. doi: 10.1038/s41388-022-02305-x. Epub ahead of print. PMID: 35459782

Activities & Honors


  • American Association for Cancer Research, 2017
  • American Academy of Pediatrics, 2017
  • Children’s Oncology Group, 2017

Videos & Media

Recent News Articles and Media Coverage

Pursuing a New Path, Johns Hopkins Medicine (November 11, 2022)

Targeting oncogenic HRAS via vertical RAS pathway inhibition in HRAS-mutated human rhabdomyosarcoma, YouTube (June 8, 2022)

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Is this you? Edit Profile
back to top button